Clinical Epigenetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2019-01-25 南医草民

兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表:
文章接受，祝福各位大神，再见了。

zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。

181 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2021-09-29 ms5000000155404164

有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2021-06-23 ms3000000783425468

开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2021-07-02 ms3000000783425468

7月2日：Reviews Completed

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2019-01-20 zhaoyang123

文章接受，祝福各位大神，再见了。

172 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2020-07-16 148b576em68暂无昵称

reviews completed 一周了，什么时候给意见啊

110 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2024-03-18 ms4000001352622128 来自湖南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：DNA甲基化;肿瘤;表观遗传
经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见

19 0

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2024-03-14 Dr.ZHAI 来自山西省

12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急

19 0

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2023-12-25 好运好运来自内蒙古

偏重的研究方向：表观遗传
经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗

32 0

[GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565807, encodeId=19eb56580e4a, content=文章接受，祝福各位大神，再见了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cf41627668, createdName=zhaoyang123, createdTime=Sun Jan 20 00:00:00 CST 2019, time=2019-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802968, encodeId=078d80296855, content=reviews completed 一周了，什么时候给意见啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=da805324168, createdName=148b576em68暂无昵称, createdTime=Thu Jul 16 10:07:02 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193972, encodeId=cbee21939e239, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：DNA甲基化;肿瘤;表观遗传 经验分享：2023年10月投稿，2024年1月3提交返修，2024年3月18号接收，没耽误博士毕业，江湖再见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5ee8339776, createdName=ms4000001352622128, createdTime=Mon Mar 18 22:59:58 CST 2024, time=2024-03-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2193138, encodeId=9f5e219313895, content=12月6日投稿，到目前还是外审，敢不敢催稿呀，真的很着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28b61996652, createdName=Dr.ZHAI, createdTime=Thu Mar 14 11:35:03 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2177041, encodeId=a63721e704106, content=偏重的研究方向：表观遗传 经验分享：请问外边显示Editor appointed，点进去是Submission under peer review。这个状态是在找编辑吗如果找到会更新状态吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Mon Dec 25 11:21:41 CST 2023, time=2023-12-25, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2127720, encodeId=034e212e72017, content=请问大家综述收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a4e8489897, createdName=ms7000000439950942, createdTime=Sat Apr 22 20:35:27 CST 2023, time=2023-04-22, status=1, ipAttribution=山东省)]

2023-04-22 ms7000000439950942 来自山东省

请问大家综述收吗？

42 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务